AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2015
Aug 31, 2015
34519_dirs_2015-08-31_7176de63-6e2b-4b24-9ebf-9b08b9392c10.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2015-08-27
Reporting Person: ROTHSCHILD JONATHAN E (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-08-27 | Common Stock, par value $0.10 per share | P | 400.0000 | $7.4500 | Acquired | 515936.0000 | Direct |
| 2015-08-27 | Common Stock, par value $0.10 per share | P | 400.0000 | $7.4600 | Acquired | 516336.0000 | Direct |
| 2015-08-27 | Common Stock, par value $0.10 per share | P | 400.0000 | $7.4700 | Acquired | 516736.0000 | Direct |
| 2015-08-27 | Common Stock, par value $0.10 per share | P | 300.0000 | $7.4300 | Acquired | 517036.0000 | Direct |
| 2015-08-27 | Common Stock, par value $0.10 per share | P | 200.0000 | $7.5200 | Acquired | 517236.0000 | Direct |
| 2015-08-27 | Common Stock, par value $0.10 per share | P | 200.0000 | $7.4400 | Acquired | 517436.0000 | Direct |
| 2015-08-27 | Common Stock, par value $0.10 per share | P | 700.0000 | $7.4100 | Acquired | 518136.0000 | Direct |
| 2015-08-27 | Common Stock, par value $0.10 per share | P | 400.0000 | $7.4500 | Acquired | 518536.0000 | Direct |
| 2015-08-27 | Common Stock, par value $0.10 per share | P | 400.0000 | $7.4600 | Acquired | 518936.0000 | Direct |
| 2015-08-28 | Common Stock, par value $0.10 per share | P | 200.0000 | $7.2000 | Acquired | 519136.0000 | Direct |
| 2015-08-28 | Common Stock, par value $0.10 per share | P | 200.0000 | $7.2900 | Acquired | 519336.0000 | Direct |
| 2015-08-28 | Common Stock, par value $0.10 per share | P | 300.0000 | $7.3400 | Acquired | 519636.0000 | Direct |
| 2015-08-28 | Common Stock, par value $0.10 per share | P | 300.0000 | $7.3100 | Acquired | 519936.0000 | Direct |
| 2015-08-28 | Common Stock, par value $0.10 per share | P | 200.0000 | $7.3900 | Acquired | 520136.0000 | Direct |
| 2015-08-28 | Common Stock, par value $0.10 per share | P | 300.0000 | $7.3200 | Acquired | 520436.0000 | Direct |
| 2015-08-28 | Common Stock, par value $0.10 per share | P | 100.0000 | $7.1700 | Acquired | 520536.0000 | Direct |
| 2015-08-28 | Common Stock, par value $0.10 per share | P | 200.0000 | $7.3700 | Acquired | 520736.0000 | Direct |
| 2015-08-28 | Common Stock, par value $0.10 per share | P | 200.0000 | $7.2500 | Acquired | 520936.0000 | Direct |
| 2015-08-28 | Common Stock, par value $0.10 per share | P | 150.0000 | $7.2600 | Acquired | 521086.0000 | Direct |
| 2015-08-28 | Common Stock, par value $0.10 per share | P | 50.0000 | $7.2300 | Acquired | 521136.0000 | Direct |
| 2015-08-31 | Common Stock, par value $0.10 per share | P | 500.0000 | $7.1700 | Acquired | 521636.0000 | Direct |
Footnotes
F1: These shares were acquired by Arterio Inc., a corporation owned solely by Mr. Rothschild.
F2: This figure includes 219,955 shares of common stock held by Arterio Inc., a corporation owned solely by Mr. Rothschild, and 39,555 shares held by the estate of Mr. Rothschild's parents. Mr. Rothschild is the executor of his parents' estate and is a one-third beneficiary of that estate. The distribution of the assets of that estate has not yet been resolved.
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23